IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Newamsterdam Pharma Company

CUSIP: N62509117 | 34 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2026

Wolverine Asset Management LLC17,464
0.0% of portfolio›$220.9K
StyleTurnoverLocationFiled
Wolverine Asset Management LLC
17,464$220.9K0.0%Deep ValueVery HighChicago, IL2026-11-02